Immunopathogenesis of Acute Flare of Chronic Hepatitis B: With Emphasis on the Role of Cytokines and Chemokines
- PMID: 35163330
- PMCID: PMC8835919
- DOI: 10.3390/ijms23031407
Immunopathogenesis of Acute Flare of Chronic Hepatitis B: With Emphasis on the Role of Cytokines and Chemokines
Abstract
Acute flares (AFs) of chronic hepatitis B usually occur during the immune-active stage (both immune clearance phase and immune reactivation phase), as the host immune system tries to control the virus. Successful host immune control over viral replication is usually presented as hepatitis B surface antigen seroclearance; however, 20-30% individuals with chronic hepatitis B may encounter repeated AFs with accumulative liver injuries, finally leading to the development of cirrhosis and hepatocellular carcinoma. AF can also develop in other clinical situations such as organ transplantation, cancer chemotherapy, and under treatment for chronic hepatitis B or treatment for chronic hepatitis C in patients with co-infected hepatitis B/hepatitis C. Understanding the natural history and immunopathogenesis of AF would help develop effective strategies to eradicate the virus and improve the clinical outcomes of patients with chronic hepatitis B. In this review article, the immunopathogenesis of AF, and the involvement of innate and adaptive immune responses on the development of hepatitis B flare will be briefly reviewed, with the emphasis on the role of cytokines and chemokines.
Keywords: acute exacerbation; acute flare; chemokine; cytokine; hepatitis B; immunopathogenesis; reactivation.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.J Gastroenterol Hepatol. 2000 May;15 Suppl:E25-30. doi: 10.1046/j.1440-1746.2000.02097.x. J Gastroenterol Hepatol. 2000. PMID: 10921378
-
Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management.J Hepatol. 2014 Dec;61(6):1407-17. doi: 10.1016/j.jhep.2014.08.033. Epub 2014 Aug 29. J Hepatol. 2014. PMID: 25178562 Review.
-
Immunopathogenesis of Hepatitis B Virus.J Infect Dis. 2017 Nov 16;216(suppl_8):S765-S770. doi: 10.1093/infdis/jix356. J Infect Dis. 2017. PMID: 29156047
-
Natural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impacts.J Biomed Sci. 2015 Oct 20;22:92. doi: 10.1186/s12929-015-0199-y. J Biomed Sci. 2015. PMID: 26487087 Free PMC article. Review.
-
[Natural history of viral hepatitis].Rev Prat. 2011 Jan;61(1):33-8. Rev Prat. 2011. PMID: 21452540 French.
Cited by
-
Treatment cessation in HBeAg-negative chronic hepatitis B: clinical response is associated with increase in specific proinflammatory cytokines.Sci Rep. 2023 Dec 18;13(1):22590. doi: 10.1038/s41598-023-50216-y. Sci Rep. 2023. PMID: 38114718 Free PMC article.
-
Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies.World J Gastroenterol. 2024 Mar 14;30(10):1295-1312. doi: 10.3748/wjg.v30.i10.1295. World J Gastroenterol. 2024. PMID: 38596493 Free PMC article. Review.
-
Chronic active and chronic inactive hepatitis B virus infection: Comparative study of genetic polymorphism and blood profile measures.PLoS One. 2025 Apr 29;20(4):e0322268. doi: 10.1371/journal.pone.0322268. eCollection 2025. PLoS One. 2025. PMID: 40299876 Free PMC article.
-
The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions.Front Immunol. 2023 Jun 8;14:1161067. doi: 10.3389/fimmu.2023.1161067. eCollection 2023. Front Immunol. 2023. PMID: 37359549 Free PMC article. Review.
-
Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients.Front Immunol. 2023 Jan 23;14:1121778. doi: 10.3389/fimmu.2023.1121778. eCollection 2023. Front Immunol. 2023. PMID: 36756119 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical